These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9988567)

  • 1. Managing the shortage of intravenous immune globulin.
    Decker EL; Gouveia WA
    Am J Health Syst Pharm; 1998 Oct; 55(20):2090, 2093. PubMed ID: 9988567
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous immune globulin therapy for antibody immunodeficiency.
    Savéry F
    Clin Ther; 1984; 7(1):69-72. PubMed ID: 6518465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful intravenous immune globulin therapy for human immunodeficiency virus-associated thrombocytopenia.
    Pollak AN; Janinis J; Green D
    Arch Intern Med; 1988 Mar; 148(3):695-7. PubMed ID: 3277573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive immunohematologic and serologic test results due to high-dose intravenous immune globulin administration.
    Garcia L; Huh YO; Fischer HE; Lichtiger B
    Transfusion; 1987; 27(6):503. PubMed ID: 3318029
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous immune globulin: its use and potential. Proceedings of a workshop. San Francisco, California, November 23, 1981.
    J Clin Immunol; 1982 Apr; 2(2 Suppl):1S-48S. PubMed ID: 7085860
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
    Han SH; Martin P; Edelstein M; Hu R; Kunder G; Holt C; Saab S; Durazo F; Goldstein L; Farmer D; Ghobrial RM; Busuttil RW
    Liver Transpl; 2003 Feb; 9(2):182-7. PubMed ID: 12548512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution plan for immune globulin intravenous during a shortage.
    Connelly JF; Verzino KC
    Am J Health Syst Pharm; 1999 Aug; 56(15):1546-8. PubMed ID: 10478995
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of chronic polymyositis following intravenous immune serum globulin therapy.
    Roifman CM; Schaffer FM; Wachsmuth SE; Murphy G; Gelfand EW
    JAMA; 1987 Jul 24-31; 258(4):513-5. PubMed ID: 3599350
    [No Abstract]   [Full Text] [Related]  

  • 9. [High-dose intravenous immunoglobulins in the treatment of immune blood cytopenia. Mechanisms of action, indications and results].
    Aymard JP; Ferry R; Janot C; Schooneman F; Streiff F
    Ann Med Interne (Paris); 1990; 141(8):689-97. PubMed ID: 2091513
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immune globulin in children with Guillain-Barré syndrome.
    Constantopoulos A; Langona E
    Neuropediatrics; 1994 Jun; 25(3):165. PubMed ID: 7969801
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous gamma-globulin in infant acquired immunodeficiency syndrome.
    Calvelli TA; Rubinstein A
    Pediatr Infect Dis; 1986; 5(3 Suppl):S207-10. PubMed ID: 3086850
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia.
    Weeks JC; Tierney MR; Weinstein MC
    N Engl J Med; 1991 Jul; 325(2):81-6. PubMed ID: 1904989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.
    National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group
    N Engl J Med; 1991 Jul; 325(2):73-80. PubMed ID: 1675763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group.
    van der Meché FG; Schmitz PI
    N Engl J Med; 1992 Apr; 326(17):1123-9. PubMed ID: 1552913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immune globulin and acute aseptic meningitis.
    Casteels-Van Daele M; Wijndaele L; Hanninck K; Gillis P
    N Engl J Med; 1990 Aug; 323(9):614-5. PubMed ID: 2381452
    [No Abstract]   [Full Text] [Related]  

  • 16. [A new immune serum globulin preparation for intravenous administration (author's transl)].
    Mozen MM; Schroeder DD; Cabasso VJ
    Arzneimittelforschung; 1980; 30(9):1484-6. PubMed ID: 7193013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comment on the article 'Intravenous immunoglobulins: pharmacological aspects and therapeutic use' by A. Hässig.
    Rohm D; Stephan W
    Vox Sang; 1987; 52(1-2):158. PubMed ID: 3604163
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms and uses of intravenous immune globulin in primary ond secondary immune deficiency disorders. Naples, Florida, October 13-14, 1988.
    J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):565-648. PubMed ID: 2794300
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of human immunoglobulins in premature infants.
    Stiehm ER
    Am J Pediatr Hematol Oncol; 1989; 11(2):235-7. PubMed ID: 2502038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manipulating the immune system with immune globulin.
    Dwyer JM
    N Engl J Med; 1992 Jan; 326(2):107-16. PubMed ID: 1727218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.